LSL TSXV · Healthcare · FY 2025-12-31
LSL Pharma Group Inc.
ABV
EPV
EBV
DBV
fair value / share
buy at or below (margin of safety applied)
margin-of-safety band
current price
values in CAD
Verdict
Avoid
Buy zone
Overvalued
Archetype
Distressed/Deficit
Confidence
●○○
Low · 1/4
Price
0.375 CAD
Market cap
47.5M CAD
P / B
1.76
P / E
—
EPS
-0.020
DPS / yield
— (0.0%)
NAV / share
0.074
Graham number
—
Z'' score
1.01
Piotroski F
3 / 9
Beneish M
-1.96
ROIC vs WACC
-0.3%
vs 8.9%
See the full orchestrator pipeline — solvency gate, lens cascade, reconciliation, archetype, decision, and confidence.
Subscribe to unlock this and every other tab for every company.
See the full ABV lens breakdown — gates, steps, and verdict.
Subscribe to unlock this and every other tab for every company.
See the full EPV lens breakdown — gates, steps, and verdict.
Subscribe to unlock this and every other tab for every company.
See the full EBV lens breakdown — gates, steps, and verdict.
Subscribe to unlock this and every other tab for every company.
See the full DBV lens breakdown — gates, steps, and verdict.
Subscribe to unlock this and every other tab for every company.